Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study
Marc Maynadié(Université de Bourgogne), Arianna Simonetti(Istituto Superiore di Sanità), Otto Visser(Netherlands Comprehensive Cancer Organisation), Carmen Martos(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Rafael Marcos‐Gragera(Generalitat de Catalunya), Milena Sant(Fondazione IRCCS Istituto Nazionale dei Tumori), Carmen Ţereanu(Fondazione IRCCS Istituto Nazionale dei Tumori), T.B. Johannesen(Cancer Registry of Norway), Risto Sankila(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Adriano Giacomin, Claudia Allemani(London Cancer), Riccardo Capocaccia(Fondazione IRCCS Istituto Nazionale dei Tumori), Roberta De Angelis(Istituto Superiore di Sanità), J.-M. Lutz
Cited by 79
Related Papers
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
|European Journal of Cancer|2021|650
The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain
|International Journal of Cancer|1992|576
Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis
|Journal of Clinical Oncology|2010|478
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
|The Lancet Oncology|2021|477
Sustainable care for children with cancer: a Lancet Oncology Commission
|The Lancet Oncology|2020|346